These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16452197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling.
    Liu B, Ordonez-Ercan D, Fan Z, Huang X, Edgerton SM, Yang X, Thor AD.
    Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M, Yao J, Yu D.
    Cancer Res; 1997 Mar 15; 57(6):1199-205. PubMed ID: 9067293
    [Abstract] [Full Text] [Related]

  • 4. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
    Chen X, Yeung TK, Wang Z.
    Biochem Biophys Res Commun; 2000 Nov 02; 277(3):757-63. PubMed ID: 11062025
    [Abstract] [Full Text] [Related]

  • 5. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.
    Mol Cancer Res; 2007 Apr 02; 5(4):393-401. PubMed ID: 17426253
    [Abstract] [Full Text] [Related]

  • 6. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
    Ursini-Siegel J, Rajput AB, Lu H, Sanguin-Gendreau V, Zuo D, Papavasiliou V, Lavoie C, Turpin J, Cianflone K, Huntsman DG, Muller WJ.
    Mol Cell Biol; 2007 Sep 02; 27(18):6361-71. PubMed ID: 17636013
    [Abstract] [Full Text] [Related]

  • 7. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X, Gao L, Wang S, Lee CK, Ordentlich P, Liu B.
    Cancer Res; 2009 Nov 01; 69(21):8403-11. PubMed ID: 19826038
    [Abstract] [Full Text] [Related]

  • 8. EGF receptor signalling is essential for electric-field-directed migration of breast cancer cells.
    Pu J, McCaig CD, Cao L, Zhao Z, Segall JE, Zhao M.
    J Cell Sci; 2007 Oct 01; 120(Pt 19):3395-403. PubMed ID: 17881501
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC, Miyake T, Parsons SJ.
    Oncogene; 2007 May 24; 26(24):3503-10. PubMed ID: 17173075
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis.
    Xue C, Wyckoff J, Liang F, Sidani M, Violini S, Tsai KL, Zhang ZY, Sahai E, Condeelis J, Segall JE.
    Cancer Res; 2006 Jan 01; 66(1):192-7. PubMed ID: 16397232
    [Abstract] [Full Text] [Related]

  • 13. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
    Walser TC, Rifat S, Ma X, Kundu N, Ward C, Goloubeva O, Johnson MG, Medina JC, Collins TL, Fulton AM.
    Cancer Res; 2006 Aug 01; 66(15):7701-7. PubMed ID: 16885372
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 01; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.
    Masuelli L, Focaccetti C, Cereda V, Lista F, Vitolo D, Trono P, Gallo P, Amici A, Monaci P, Mattei M, Modesti M, Forni G, Kraus MH, Muraro R, Modesti A, Bei R.
    Int J Oncol; 2007 Feb 01; 30(2):381-92. PubMed ID: 17203220
    [Abstract] [Full Text] [Related]

  • 20. Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
    Aurisicchio L, Marra E, Luberto L, Carlomosti F, De Vitis C, Noto A, Gunes Z, Roscilli G, Mesiti G, Mancini R, Alimandi M, Ciliberto G.
    J Cell Physiol; 2012 Oct 01; 227(10):3381-8. PubMed ID: 22213458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.